abstract |
The compound, acid morpholino-N-ethyl ester ((3- (2-amino-1,2-dioxoethyl) -2-ethyl-l- (phenylmethyl) -1H-indole-4-yl) oxy) acetic acid is described together with its use as a highly bioavailable indole compound to inhibit the release of fatty acids mediated by sPLA2 for the treatment of conditions such as septic shock. |